Nooms prices were clear and affordable
Protocol 2: tirzepatide microdose for autoimmune inflammation Goal: Leverage dual GIP/GLP-1 receptor activation for broader anti-inflammatory coverage Starting dose: 0.5 mg tirzepatide subcutaneously, once weekly Week 1 to 6: Hold at 0.5 mg
They work through appetite and metabolic pathways, not by directly altering estrogen, progesterone, or testosterone levels
The protein, because it's not being reabsorbed back through the lymphatic channels, is inflammatory
Novo at one point struck a deal with Hims to distribute Wegovy at a cheaper cash-pay price, but the drugmakers abruptly called off the deal in June and accused Hims of illegal mass compounding and deceptive marketing. Since then, speculation that Novo might sue Hims has lingered, with traders on Kalshi pegging the odds at about 24% by the end of the year
GLP-1 and the Future of Nutrition: Innovations in AI and Tech Outside of retail, in todays AI and digital era, the impact of GLP-1 extends to businesses integrating digital solutions into nutrition and health
